Estimating the Spatial Accessibility to Blood Group and Rhesus Type Point-of-Care Testing for Maternal Healthcare in Ghana.
Ghana
Upper East Region
blood group
maternal healthcare
point-of-care testing
rhesus type
spatial accessibility
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
05 Nov 2019
05 Nov 2019
Historique:
received:
29
09
2019
revised:
21
10
2019
accepted:
29
10
2019
entrez:
8
11
2019
pubmed:
7
11
2019
medline:
7
11
2019
Statut:
epublish
Résumé
In Ghana, a blood group and rhesus type test is one of the essential recommended screening tests for women during antenatal care since blood transfusion is a key intervention for haemorrhage. We estimated the spatial accessibility to health facilities for blood group and type point-of-care (POC) testing in the Upper East Region (UER), Ghana. We assembled the attributes and spatial data of hospitals, clinics, and medical laboratories providing blood group and rhesus type POC testing in the UER. We also obtained the spatial data of all the 131 towns, and 94 health centres and community-based health planning and services (CHPS) compounds providing maternal healthcare in the region. We further obtained the topographical data of the region, and travel time estimated using an assumed tricycle speed of 20 km/h. We employed ArcGIS 10.5 to estimate the distance and travel time and locations with poor spatial access identified for priority improvement. In all, blood group and rhesus type POC testing was available in 18 health facilities comprising eight public hospitals and six health centres, one private hospital, and three medical laboratories used as referral points by neighbouring health centres and CHPS compounds without the service. Of the 94 health centres and CHPS compounds, 51.1% (48/94) and 66.4% (87/131) of the towns were within a 10 km range to a facility providing blood group and rhesus type testing service. The estimated mean distance to a health facility for blood group and rhesus POC testing was 8.9 ± 4.1 km, whilst the mean travel time was 17.8 ± 8.3 min. Builsa South district recorded the longest mean distance (25.6 ± 7.4 km), whilst Bongo district recorded the shortest (3.1 ± 1.9 km). The spatial autocorrelation results showed the health facilities providing blood group and rhesus type POC testing were randomly distributed in the region (Moran Index = 0.29; z-score = 1.37; This study enabled the identification of district variations in spatial accessibility to blood group and rhesus type POC testing in the region for policy decisions. We urge the health authorities in Ghana to evaluate and implement recommended POC tests such as slide agglutination tests for blood group and rhesus type testing in resource-limited settings.
Sections du résumé
BACKGROUND
BACKGROUND
In Ghana, a blood group and rhesus type test is one of the essential recommended screening tests for women during antenatal care since blood transfusion is a key intervention for haemorrhage. We estimated the spatial accessibility to health facilities for blood group and type point-of-care (POC) testing in the Upper East Region (UER), Ghana.
METHODS
METHODS
We assembled the attributes and spatial data of hospitals, clinics, and medical laboratories providing blood group and rhesus type POC testing in the UER. We also obtained the spatial data of all the 131 towns, and 94 health centres and community-based health planning and services (CHPS) compounds providing maternal healthcare in the region. We further obtained the topographical data of the region, and travel time estimated using an assumed tricycle speed of 20 km/h. We employed ArcGIS 10.5 to estimate the distance and travel time and locations with poor spatial access identified for priority improvement.
FINDINGS
RESULTS
In all, blood group and rhesus type POC testing was available in 18 health facilities comprising eight public hospitals and six health centres, one private hospital, and three medical laboratories used as referral points by neighbouring health centres and CHPS compounds without the service. Of the 94 health centres and CHPS compounds, 51.1% (48/94) and 66.4% (87/131) of the towns were within a 10 km range to a facility providing blood group and rhesus type testing service. The estimated mean distance to a health facility for blood group and rhesus POC testing was 8.9 ± 4.1 km, whilst the mean travel time was 17.8 ± 8.3 min. Builsa South district recorded the longest mean distance (25.6 ± 7.4 km), whilst Bongo district recorded the shortest (3.1 ± 1.9 km). The spatial autocorrelation results showed the health facilities providing blood group and rhesus type POC testing were randomly distributed in the region (Moran Index = 0.29; z-score = 1.37;
CONCLUSION
CONCLUSIONS
This study enabled the identification of district variations in spatial accessibility to blood group and rhesus type POC testing in the region for policy decisions. We urge the health authorities in Ghana to evaluate and implement recommended POC tests such as slide agglutination tests for blood group and rhesus type testing in resource-limited settings.
Identifiants
pubmed: 31694228
pii: diagnostics9040175
doi: 10.3390/diagnostics9040175
pmc: PMC6963207
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Ghana Med J. 2013 Dec;47(4):158-63
pubmed: 24669020
Indian J Anaesth. 2014 Sep;58(5):524-8
pubmed: 25535412
BMC Public Health. 2012 Nov 16;12:991
pubmed: 23158554
Diagnostics (Basel). 2017 Nov 29;7(4):null
pubmed: 29186013
Bull World Health Organ. 2004 Apr;82(4):265-73
pubmed: 15259255
Health Econ Rev. 2012 Aug 06;2(1):14
pubmed: 22866869
Int J Health Geogr. 2016 Mar 01;15:10
pubmed: 26932155
EClinicalMedicine. 2019 Jul 03;13:74-80
pubmed: 31517264
BMC Public Health. 2019 Jun 10;19(1):718
pubmed: 31182068
Soc Sci Med. 2006 Aug;63(3):691-705
pubmed: 16574290
Int J Health Geogr. 2004 Feb 26;3(1):3
pubmed: 14987337
Heliyon. 2019 Feb 19;5(2):e01236
pubmed: 30828664
Health Place. 2014 Nov;30:127-33
pubmed: 25262490
Lancet Glob Health. 2014 Jun;2(6):e323-33
pubmed: 25103301
BMC Public Health. 2011 Mar 10;11:159
pubmed: 21392387
Glob Health Action. 2015 Nov 20;8:29443
pubmed: 26593274
Health Econ Rev. 2017 Dec;7(1):16
pubmed: 28444572
J Health Popul Nutr. 2009 Apr;27(2):259-70
pubmed: 19489420